The objective of the Global Longitudinal Registry of Osteoporosis in Women (GLOW) study is to improve
our understanding of the risk and prevention of osteoporosis-related fractures among females who are 55 years of age and older over a five year period.
Patients are sent a survey approximately once a year. They are asked to complete the survey and return to us in a stamped self-addressed envelope.
- Principal Investigator
- Kurt N. Ransohoff, MD
- Linda Chapman, CCRC
- Trial Status
- Ongoing, closed to enrollment
- Study Length
- 5 years